The use of chemosensitizers to enhance the response to conventional therapy in triple-negative breast cancer patients
Author:
Affiliation:
1. Department of Anatomic Pathology, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
Publisher
Future Medicine Ltd
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Link
https://www.futuremedicine.com/doi/pdf/10.2217/bmt-2017-0030
Reference23 articles.
1. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
2. Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
3. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy
4. A nanoparticulate pre-chemosensitizer for efficacious chemotherapy of multidrug resistant breast cancer
5. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The combination of Curcumin and Doxorubicin on targeting PI3K/AKT/mTOR signaling pathway: an in vitro and molecular docking study for inhibiting the survival of MDA-MB-231;In Silico Pharmacology;2024-06-21
2. Chitosan-grafted folic acid decorated one-dimensional GONS: A biocompatible drug cargo for targeted co-delivery of anticancer agents;International Journal of Biological Macromolecules;2024-06
3. Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy;Phytotherapy Research;2024-02-14
4. Synergism of Curcumin and Doxorubicin Proves an Effective Anticancer Therapeutics Against Breast Cancer: An in vitro Study;2023-07-13
5. Understanding the role of the natural warriors: phytochemicals in breast cancer chemoprevention;Recent Frontiers of Phytochemicals;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3